Teri Jolanda Kapp, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 524 W Main St, Decaturville, TN 38329 Phone: 731-206-0452 |
Mrs. Suzanne Park Enochs, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 524 W Main St, Decaturville, TN 38329 Phone: 731-852-3591 |
Melissa Jones Speech-Language Pathologist Medicare: May Accept Medicare Assignments Practice Location: 1847 Old Stage Rd, Decaturville, TN 38329 Phone: 731-549-6364 |
Amber Diane Walker, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 59 W Main St, Decaturville, TN 38329 Phone: 423-622-1551 |
Anne Dora Wright, SLP/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 59 W Main St, Decaturville, TN 38329 Phone: 423-622-1551 Fax: 423-622-1556 |
News Archive
ANDalyze sensor/Fluorimeter platform solution for simplifying the on-site testing and analysis of water for heavy metal contamination is now being sold in China and Australia as a replacement to more time consuming testing methods such as electrochemical and reagent testing methods that require significant training.
As President Obama addresses the nation on health care reform, a new analysis by the Center for Immigration Studies estimates that 6.6 million uninsured illegal immigrants could receive benefits under the House health reform bill (H.R. 3200). While the bill states that illegal immigrants are not eligible for the new taxpayer-funded affordability credits, there is nothing in the bill to enforce this provision.
Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.
Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.
New research shows people who have used amphetamines such as benzedrine and dexedrine appear to be at an increased risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.
› Verified 6 days ago